Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Auspherix Ltd.
Freshly Appointed Auspherix CEO Highlights New Antibiotic Class
Dr Neil Miller, the recently-appointed CEO of UK-based biotech Auspherix, talks to Scrip about the company's new class of antibiotics and how it plans to help address the worldwide antimicrobial resistance crisis.
Start-Up Execs On The Move, January 2016
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Venture Funding Deals, July 2015
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June 2015.
Emergings In Brief, June 2015
Brief profiles of these recently formed companies: Auspherix, Medella Health, OmniSeq, and Xtuit Pharmaceuticals.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.